What do industry leaders have to say about the RNA Drug Discovery Summit as it brings together the global RNA community this year?
2026 Speakers
“This meeting is the main chance each year for all of the thought leaders in drugging RNA with small molecules to get in one room and exchange ideas. If you want to know what the latest approaches are to cracking the RNA-drugging problem, you’ll find them here.”
Chief Technology Officer,
Wayfinder Biosciences
“As RNA-targeted drug discovery transitions from emerging science to validated therapeutic strategy, this summit provides the essential ecosystem for collaboration and knowledge exchange. Engaging with fellow innovators allows us to collectively address the field's challenges, explore new frontiers, and build partnerships that will define the next generation of medicines. In 2026 for my 8th attendance, I will be again thrilled to engage & exchange with my scientific peers of this booming field.”
Head of Small Molecules Medicinal
Chemistry, Sanofi
“The RNA-targeted drug discovery summit is a premier event that brings together a wide range of scientists involved in RNA drug discovery. It's a great opportunity to catch up on the latest developments in the field and compare notes with peers. I highly recommend this event to all practitioners in the area.”
Vice President, Medicinal Chemistry,
ReviR Therapeutics
Past Speakers
“The tightknit community was enjoyable. All of the talks were well attended. The mixer on the first conference day helped me to get to know people early on, which was great as a first-time attendee”
Co-Founder & Chief Technology Officer,
Wayfinder Biosciences
“The meeting was exceptionally well organized, and I truly enjoyed the depth and openness of the scientific discussions.
What stood out to me was the strong balance between fundamental RNA biology, emerging technologies, and translational perspectives across pharma and biotech.
The highly engaged audience and the frank exchange of technical challenges made the sessions particularly valuable.
It was also inspiring to see how different groups are approaching RNA-targeted small molecules from diverse angles, which made the conversations both enjoyable and thought-provoking.”
Co-Founder, Representative Director, President & Chief Executive Officer,
xFOREST Therapeutics
“I greatly enjoyed the panel discussions, which were highly interactive and offered different perspectives from leaders in the field. It was particularly exciting to learn about the new chemical entities currently in clinical trials, as well as the novel strategies for RNA modulation and tools for discovery. Overall, the summit was both informative and inspiring, giving me valuable insights and ideas that I can bring back to my own work.”
Chief Scientific Officer,
Veritas In Silico
“RNA-Targeted Drug Discovery Summit has become the main annual event for RNA centric small molecule drug discovery community. It is the most representative congress to learn about the progress in the field, connect with colleagues from other companies and laboratories.”
Chief Scientific Officer,
Ribonaut Therapeutics
Past Sponsor
“The RNA conference provides the best opportunity to engage with the largest number of RNA-targeting companies, most of whom attend other conferences but rarely the same ones.”
Group Leader, Early Discovery Chemistry,
PTC Therapeutics
